Nature Communications (Jan 2022)

Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells

  • Yanyun Du,
  • Qianwen Peng,
  • Du Cheng,
  • Ting Pan,
  • Wanwei Sun,
  • Heping Wang,
  • Xiaojian Ma,
  • Ruirui He,
  • Huazhi Zhang,
  • Zhihui Cui,
  • Xiong Feng,
  • Zhiqiang Liu,
  • Tianxin Zhao,
  • Wenjun Hu,
  • Lei Shen,
  • Wenyang Jiang,
  • Na Gao,
  • Bradley N. Martin,
  • Cun-Jin Zhang,
  • Zhanguo Zhang,
  • Chenhui Wang

DOI
https://doi.org/10.1038/s41467-021-27936-8
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 16

Abstract

Read online

Cancer cells producing ligands for the immune checkpoint molecules PD-1 and CTLA-4 is an important mechanism of tumour immune resistance. Here authors show that BTNL2 expression on cancer cells generates a dysfunctional tumour immune microenvironment via promoting IL-17A-producing γδ T cells.